Patents Assigned to Gateway Health Alliances, Inc.
  • Publication number: 20090274784
    Abstract: In one embodiment, a composition containing an effective amount of Cissus quadrangularis and one or more plants selected from the Brillantaisia and Vernonia plant families whereby the composition reduces the amount of fat absorbed or reduces weight in a mammal. Such compositions have beneficial activity principally in controlling weight gain and obesity, especially in conjunction with chitosan or a chitosan derivative and an antioxidant such as vitamin C.
    Type: Application
    Filed: July 16, 2009
    Publication date: November 5, 2009
    Applicant: GATEWAY HEALTH ALLIANCES, INC.
    Inventor: Julius Enyong Oben
  • Publication number: 20090227514
    Abstract: Methods and compositions using plants from the Irvingiaceae family to reduce body weight in a mammal. Methods and compositions using the Irvingia gabonensis plant to reduce lipid levels, BMI and body weight, blood pressure, triglyceride levels, total amount of fat stored in the body, cholesterol levels, salivary and pancreatic alpha-amylase activity and pancreatic lipase activity, LDL cholesterol, to increase HDL cholesterol, to control blood glucose and to prevent or reduce the effects of insulin resistance, diabetes, and heart disease.
    Type: Application
    Filed: May 22, 2009
    Publication date: September 10, 2009
    Applicant: GATEWAY HEALTH ALLIANCES, INC.
    Inventor: Julius Oben
  • Publication number: 20090226553
    Abstract: Methods and compositions using plants from the Irvingiaceae family to reduce body weight in a mammal. Methods and compositions using the Irvingia gabonensis plant to reduce lipid levels, BMI and body weight, blood pressure, triglyceride levels, total amount of fat stored in the body, cholesterol levels, salivary and pancreatic alpha-amylase activity and pancreatic lipase activity, LDL cholesterol, to increase HDL cholesterol, to control blood glucose and to prevent or reduce the effects of insulin resistance, diabetes, and heart disease.
    Type: Application
    Filed: May 22, 2009
    Publication date: September 10, 2009
    Applicant: GATEWAY HEALTH ALLIANCES, INC.
    Inventor: Julius Oben
  • Patent number: 7537790
    Abstract: Methods and composition using plants from the Irvingiaceae family to reduce or prevent one or more symptoms of Syndrome X in a mammal and provide numerous other health related benefits. Methods and compositions using the Irvinga gabonensis plant to reduce lipid levels, BMI and body weight, blood pressure, triglyceride levels, total amount of stored in the body, cholesterol levels, salivary and pancreatic alpha-amylase activity and pancreatic lipase activity, LDL cholesterol, to increase HDL cholesterol, to control blood glucose and to prevent or reduce the effects of insulin resistance, diabetes, and heart disease.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: May 26, 2009
    Assignee: Gateway Health Alliances, Inc.
    Inventor: Julius Oben
  • Publication number: 20090076129
    Abstract: The present invention relates generally to methods and related compositions using flavonoids and/or indanes extracted from the stems and leaves of C. quadrangularis to reduce weight and inhibit lipase, ?-amylase and ?-glucosidase activity in mammals. By example and not by way of limitation, embodiments of the present disclosure, a composition and related methods for reducing body weight and/or inhibiting any combination of lipase, ?-amylase and ?-glucosidase is provided. The composition contains an effective amount of one or more flavonoids or indanes selected from 3-O-rhamnopyranosylkaempferol, 3-(4-hydroxybenzylidene)-2-(2,5-dihydroxyphenyl)-1-(4-hydroxyphenyl)indane-4,6-diol, quercitrin, rhamnitrin, rhamnocitrin, quercitrin-3-O?-acetate and parthenocissin A.
    Type: Application
    Filed: September 13, 2007
    Publication date: March 19, 2009
    Applicant: GATEWAY HEALTH ALLIANCES, INC.
    Inventor: Julius Enyong Oben
  • Publication number: 20080085332
    Abstract: The present invention provides for compositions and related methods using extracts from the Cissus quadrangularis plant to improve and eliminate various cardiovascular risk factors and metabolic risk factors that cause Syndrome X. Controlled university studies demonstrated that 300 mg Cissus quadrangularis plant extract provided to obese humans daily for six weeks was effective to provide numerous health benefits including weight loss, improving the bodies fat burning mechanisms, increasing serum serotonin levels which causes appetite suppression and prevents binge eating and/or emotional eating, reducing total cholesterol, LDL cholesterol, triglyceride levels, fasting blood sugar levels and blood pressure, and increasing HDL or “good” cholesterol levels.
    Type: Application
    Filed: October 10, 2007
    Publication date: April 10, 2008
    Applicant: GATEWAY HEALTH ALLIANCES, INC
    Inventor: Shil Kothari
  • Publication number: 20080081084
    Abstract: The present invention provides for compositions and related methods using extracts from the Cissus quadrangularis plant to improve and eliminate various cardiovascular risk factors and metabolic risk factors that cause Syndrome X. Controlled university studies demonstrated that 300 mg Cissus quadrangularis plant extract provided to obese humans daily for six weeks was effective to provide numerous health benefits including weight loss, improving the bodies fat burning mechanisms, increasing serum serotonin levels which causes appetite suppression and prevents binge eating and/or emotional eating, reducing total cholesterol, LDL cholesterol, triglyceride levels, fasting blood sugar levels and blood pressure, and increasing HDL or “good” cholesterol levels.
    Type: Application
    Filed: October 10, 2007
    Publication date: April 3, 2008
    Applicant: GATEWAY HEALTH ALLIANCES, INC
    Inventor: Shil Kothari
  • Publication number: 20080081083
    Abstract: The present invention provides for compositions and related methods using extracts from the Cissus quadrangularis plant to improve and eliminate various cardiovascular risk factors and metabolic risk factors that cause Syndrome X. Controlled university studies demonstrated that 300 mg Cissus quadrangularis plant extract provided to obese humans daily for six weeks was effective to provide numerous health benefits including weight loss, improving the bodies fat burning mechanisms, increasing serum serotonin levels which causes appetite suppression and prevents binge eating and/or emotional eating, reducing total cholesterol, LDL cholesterol, triglyceride levels, fasting blood sugar levels and blood pressure, and increasing HDL or “good” cholesterol levels.
    Type: Application
    Filed: October 10, 2007
    Publication date: April 3, 2008
    Applicant: GATEWAY HEALTH ALLIANCES, INC
    Inventor: Shil Kothari
  • Patent number: 7175859
    Abstract: A composition comprising extract of one or more plants of one or more of the following plant families: Cissus, Vernonia and Brillantasia. Such compositions have beneficial activity principally in controlling weight gain and obesity, especially in conjunction with chitosan or a chitosan derivative and an antioxidant such as vitamin C.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: February 13, 2007
    Assignee: Gateway Health Alliances, Inc.
    Inventor: Julius Enyong Oben